Literature DB >> 27668804

Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.

Angela M Bengtson1, Brian W Pence, Bradley N Gaynes, E Byrd Quinlivan, Amy D Heine, Julie K OʼDonnell, Heidi M Crane, W Christopher Mathews, Richard D Moore, Daniel Westreich, Conall OʼCleirigh, Katerina Christopoulos, Matthew J Mimiaga, Michael J Mugavero.   

Abstract

BACKGROUND: Depression affects 20%-30% of people with HIV. Randomized controlled trials (RCTs) have demonstrated the effectiveness of interventions to improve depression among HIV-infected adults, but typically have highly selected populations which may limit generalizability. Inverse probability of sampling weights (IPSW) is a recently proposed method to transport (or standardize) findings from RCTs to a specific external target population.
METHODS: We used IPSW to transport the 6-month effect of the Measurement-Based Care (MBC) intervention on depression from the SLAM DUNC trial to a population of HIV-infected, depressed adults in routine care in the United States between 2010 and 2014.
RESULTS: In the RCT, MBC was associated with an improvement in depression at 6 months of 3.6 points on the Hamilton Depression Rating scale [95% confidence interval (CI): -5.9 to -1.3]. When IPSW were used to standardize results from the trial to the target population, the intervention effect was attenuated by 1.2 points (mean improvement 2.4 points; 95% CI: -6.1 to 1.3).
CONCLUSIONS: If implemented among HIV-infected, depressed adults in routine care, MBC may be less effective than in the RCT but can still be expected to reduce depression. Attenuation of the intervention effect among adults in routine care reflects the fact that the trial enrolled a larger proportion of individuals for whom the intervention was more effective. Given the burden of depression among HIV-infected adults, more effective interventions to improve depression are urgently needed. However, examining the transportability of trial findings is essential to understand whether similar effects can be expected if interventions are scaled-up.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27668804      PMCID: PMC5085843          DOI: 10.1097/QAI.0000000000001131

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  38 in total

1.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

2.  Meta-analysis of the relationship between HIV infection and risk for depressive disorders.

Authors:  J A Ciesla; J E Roberts
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

3.  Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.

Authors:  Diane Warden; Madhukar H Trivedi; Thomas Carmody; Marisa Toups; Sidney Zisook; Ira Lesser; Alyson Myers; Kolette Ring Benji Kurian; David Morris; A John Rush
Journal:  J Psychiatr Pract       Date:  2014-03       Impact factor: 1.325

Review 4.  Generalizability of studies on mental health treatment and outcomes, 1981 to 1996.

Authors:  Joel T Braslow; Naihua Duan; Sarah L Starks; Antonio Polo; Elizabeth Bromley; Kenneth B Wells
Journal:  Psychiatr Serv       Date:  2005-10       Impact factor: 3.084

5.  Progression to AIDS: the effects of stress, depressive symptoms, and social support.

Authors:  J Leserman; E D Jackson; J M Petitto; R N Golden; S G Silva; D O Perkins; J Cai; J D Folds; D L Evans
Journal:  Psychosom Med       Date:  1999 May-Jun       Impact factor: 4.312

6.  The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.

Authors:  Brian W Pence; Bradley N Gaynes; Julie L Adams; Nathan M Thielman; Amy D Heine; Michael J Mugavero; Teena McGuinness; James L Raper; James H Willig; Kristen G Shirey; Michelle Ogle; Elizabeth L Turner; E Byrd Quinlivan
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

7.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

8.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

9.  Assessing the generalizability of randomized trial results to target populations.

Authors:  Elizabeth A Stuart; Catherine P Bradshaw; Philip J Leaf
Journal:  Prev Sci       Date:  2015-04

10.  Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.

Authors:  Stephen R Wisniewski; A John Rush; Andrew A Nierenberg; Bradley N Gaynes; Diane Warden; James F Luther; Patrick J McGrath; Philip W Lavori; Michael E Thase; Maurizio Fava; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2009-04-01       Impact factor: 18.112

View more
  11 in total

1.  Fertility Intentions and Clinical Care Attendance Among Women Living with HIV in South Africa.

Authors:  Katherine B Rucinski; Sheree R Schwartz; Kimberly A Powers; Brian W Pence; Benjamin H Chi; Vivian Black; Helen Rees; Audrey E Pettifor
Journal:  AIDS Behav       Date:  2020-06

2.  Measurement of depression treatment among patients receiving HIV primary care: Whither the truth?

Authors:  Bethany L DiPrete; Brian W Pence; David J Grelotti; Bradley N Gaynes
Journal:  J Affect Disord       Date:  2018-01-03       Impact factor: 4.839

3.  Generalisability of an online randomised controlled trial: an empirical analysis.

Authors:  Cheng Wang; Katie R Mollan; Michael G Hudgens; Joseph D Tucker; Heping Zheng; Weiming Tang; Li Ling
Journal:  J Epidemiol Community Health       Date:  2017-11-28       Impact factor: 3.710

4.  Invited Commentary: Causal Inference Across Space and Time-Quixotic Quest, Worthy Goal, or Both?

Authors:  Jessie K Edwards; Catherine R Lesko; Alexander P Keil
Journal:  Am J Epidemiol       Date:  2017-07-15       Impact factor: 4.897

5.  Serving the Co-Morbid Mental Health and Substance Use Needs of People with HIV.

Authors:  Fiona N Conway; Michele A Rountree; Kristian V Jones
Journal:  Community Ment Health J       Date:  2021-01-02

6.  Depressive Symptoms and Sexually Transmitted Disease: Evidence from a Low-Income Neighborhood of New York City.

Authors:  Boshen Jiao; Zafar Zafari; Kai Ruggeri; Sharifa Z Williams
Journal:  Community Ment Health J       Date:  2019-05-09

7.  Depression Symptom Trajectories Among Mothers Living with HIV in Rural Uganda.

Authors:  Itziar Familiar; Alla Sikorskii; Sarah Murray; Horacio Ruisenor-Escudero; Noeline Nakasujja; Clinton Korneffel; Michael Boivin; Judith Bass
Journal:  AIDS Behav       Date:  2019-12

8.  Suicidality among nonadherent patients living with HIV in Buenos Aires, Argentina: prevalence and correlates.

Authors:  Violeta J Rodriguez; Omar Sued; Diego Cecchini; Lissa N Mandell; Lina M Bofill; Stephen M Weiss; Isabel Cassetti; Pedro Cahn; Deborah L Jones
Journal:  AIDS Care       Date:  2018-04-01

9.  Generalizability of Subgroup Effects.

Authors:  Marissa J Seamans; Hwanhee Hong; Benjamin Ackerman; Ian Schmid; Elizabeth A Stuart
Journal:  Epidemiology       Date:  2021-05-01       Impact factor: 4.860

10.  Viral Suppression Is Associated with HIV Treatment Self-Efficacy in a Cohort of Women in Washington, DC.

Authors:  Amanda Blair Spence; Katherine Michel; Cuiwei Wang; Mary Ann Dutton; Kathryn Lee; Daniel Merenstein; Lucile Adams-Campbell; Katheryn Bell; Anjali Kikkisetti; Allison Doyle; Mikayla Cochrane; Lakshmi Goparaju; Seble Kassaye
Journal:  AIDS Patient Care STDS       Date:  2021-03       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.